Will Theravance Biopharma Finally Break Out in 2020?
Drug developer Theravance Biopharma (NASDAQ: TBPH) is not your typical biotech company.
It emerged in 2014 from a spinoff of the R&D branch of its parent company, now called Innoviva (NASDAQ: INVA). Shareholders in Innoviva received a dividend of Theravance Biopharma stock. The R&D efforts focus on inflammation and immunology.
IMAGE SOURCE: GETTY IMAGES.
Source Fool.com
